- Home
- IMCR vs DHT Comparison
IMCR vs DHT Comparison
Compare IMCR & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- DHT
- Stock Information
- Founded
- IMCR 2008
- DHT 2005
- Country
- IMCR United Kingdom
- DHT Bermuda
- Employees
- IMCR N/A
- DHT N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- DHT Marine Transportation
- Sector
- IMCR Health Care
- DHT Consumer Discretionary
- Exchange
- IMCR Nasdaq
- DHT Nasdaq
- Market Cap
- IMCR 1.5B
- DHT 1.6B
- IPO Year
- IMCR 2021
- DHT 2005
- Fundamental
- Price
- IMCR $29.79
- DHT $11.02
- Analyst Decision
- IMCR Buy
- DHT Strong Buy
- Analyst Count
- IMCR 11
- DHT 4
- Target Price
- IMCR $59.11
- DHT $13.75
- AVG Volume (30 Days)
- IMCR 264.3K
- DHT 1.7M
- Earning Date
- IMCR 05-07-2025
- DHT 05-06-2025
- Dividend Yield
- IMCR N/A
- DHT 7.37%
- EPS Growth
- IMCR N/A
- DHT 4.76
- EPS
- IMCR N/A
- DHT 1.10
- Revenue
- IMCR $333,581,000.00
- DHT $563,104,000.00
- Revenue This Year
- IMCR $20.26
- DHT N/A
- Revenue Next Year
- IMCR $8.49
- DHT $25.01
- P/E Ratio
- IMCR N/A
- DHT $10.12
- Revenue Growth
- IMCR 25.75
- DHT N/A
- 52 Week Low
- IMCR $23.15
- DHT $8.67
- 52 Week High
- IMCR $62.22
- DHT $12.80
- Technical
- Relative Strength Index (RSI)
- IMCR 52.81
- DHT 57.57
- Support Level
- IMCR $27.88
- DHT $9.91
- Resistance Level
- IMCR $31.38
- DHT $11.43
- Average True Range (ATR)
- IMCR 1.62
- DHT 0.30
- MACD
- IMCR 0.02
- DHT 0.09
- Stochastic Oscillator
- IMCR 58.49
- DHT 73.03
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.